Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: Dose or duration?

Journal of the American Society of Nephrology

Volumn 24, Issue 1, 2013, Pages 7-9

  Hodson, Elisabeth M ^a   Craig, Jonathan C ^a  

^a not available

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREDNISOLONE;

BACTERIAL INFECTION; BEHAVIOR CHANGE; BONE DENSITY; CORTICOSTEROID THERAPY; DOSE RESPONSE; EDITORIAL; EYE DISEASE; FOLLOW UP; GROWTH RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MOON FACE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT; STEROID SENSITIVE NEPHROTIC SYNDROME; STRIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS INFECTION;

EID: 84871895518     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012111093     Document Type: Editorial

References (14)

1. El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JCF, van Wijk JAE: Nephrotic syndrome in The Netherlands: A population-based cohort study and a review of the literature. Pediatr Nephrol 26: 1241-1246, 2011
2. McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM: Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16: 1040-1044, 2001 (Pubitemid 34026718)
3. Koskimies O, Vilska J, Rapola J, Hallman N: Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57: 544-548, 1982 (Pubitemid 12082231)
4. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr: Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8: 769-776, 1997
5. Abramowicz M, Barnett HL, Edelmann CM Jr, Greifer I, Kobayashi O, Arneil GC, Barron BA, Gordillo-P G, Hallman N, Tiddens HA: Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet 1: 959-961, 1970
6. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. A study of the Arbetsgemeinschaft für Pädiatrische Nephrologie. N Engl JMed 306: 451-454, 1982
7. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie". Lancet 1: 401-403, 1979
8. Hodson EM, Willis NS, Craig JC: Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (4): CD001533, 2007
9. Teeninga N, Kist-van Holthe J, van Rijskwijk N, de Mos N, Wetzels JF, Nauta J: Extending prednisolone therapy does not reduce relapse in childhood nephrotic syndrome. J Am Soc Nephrol 24: 149-159, 2012
10. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352: 609-613, 1998 (Pubitemid 28380142)
11. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin J-J, Trachtman H, Greenbaum LA: Management of childhood onset nephrotic syndrome. Pediatrics 124: 747-757, 2009
12. Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M; Indian Pediatric Nephrology Group, Indian Academy of Pediatrics: Management of steroid sensitive nephrotic syndrome: Revised guidelines. Indian Pediatr 45: 203-214, 2008 (Pubitemid 351457458)
13. Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group: KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int Suppl 2: 139-274, 2012
14. French National Authority for Health: Syndrome néphrotique idiopathique de l'enfant. French National Authority for Health, 2008, pp 1-22